The role of PNPLA3 I148M polymorphism in shaping clinical and morphological characteristics and the progressive course of MASLD in a Russian cohort
https://doi.org/10.24884/1609-2201-2026-105-1-121-124
About the Authors
V. P. Gomonova
Saint Petersburg State University
Russian Federation
Russian Federation
Veronika P. Gomonova, Assistant at the Scientific, Clinical and Educational Center for Gastroenterology and Hepatology, Medical Institute
Saint Petersburg
K. L. Raikhelson
Saint Petersburg State University
Russian Federation
Russian Federation
Karina L. Raikhelson, Dr. of Sci. (Med.), Professor at the Scientific, Clinical and Educational Center for Gastroenterology and Hepatology, Medical Institute; Professor at the Department of General Medical Practice, Pavlov University
Saint Petersburg
References
1. Souza M., Al-Sharif L. Diaz I. et al. Global epidemiology and implications of PNPLA3 I148M variant in metabolic dysfunctionassociated steatotic liver disease: a systematic review and meta-analysis. J. Clin. Exp. Hepatol. 2025;15(3):102495.
2. Salari N., Darvishi N., Mansouri K. et al. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. BMC Endocr. Disord. 2021;21(1):125.
Review
For citations:
Gomonova V.P., Raikhelson K.L. The role of PNPLA3 I148M polymorphism in shaping clinical and morphological characteristics and the progressive course of MASLD in a Russian cohort. New St. Petersburg Medical Records. 2026;(1):121-124. (In Russ.) https://doi.org/10.24884/1609-2201-2026-105-1-121-124
Views:
115
JATS XML
Email this article 